SGAM
CMD

Smith Group Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Smith Group Asset Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-280
Closed -$22K – 395
2021
Q1 		$22K Buy
+280
New +$21.9K ﹤0.01% 198

Smith Group Asset Management's CMD Position: Q2 2021 in Review

Smith Group Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 280 shares — an estimated $22K sold.

Smith Group Asset Management first reported a position in CMD in Q1 2021 and held it in 1 quarter. The position peaked at $22K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Smith Group Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Smith Group Asset Management sold 280 Cantel Medical Corporation shares in Q2 2021, an estimated $22K.
  • Smith Group Asset Management first reported a position in Cantel Medical Corporation in Q1 2021 and held it in 1 quarter.
  • Smith Group Asset Management's Cantel Medical Corporation position peaked at $22K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Smith Group Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.